Clinical Trial: Stem Cell Therapy in Muscular Dystrophy
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Role of Autologous Mononuclear Cell Therapy in Muscular Dystrophy
Brief Summary: The purpose of this study was to analyze the effect of autologous bone marrow mononuclear cells in muscular dystrophy.
Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute
Current Primary Outcome: Manual Muscle Testing [ Time Frame: 1 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Neurogen Brain and Spine Institute
Dates:
Date Received: September 12, 2014
Date Started: January 2009
Date Completion: May 2018
Last Updated: September 23, 2016
Last Verified: September 2016